# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-24-078451
Filing Date
2024-07-09
Accepted
2024-07-09 07:30:18
Documents
17
Period of Report
2024-07-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2419051d1_8k.htm iXBRL | 8-K | 28313
2 | EXHIBIT 99.1 | tm2419051d1_ex99-1.htm | EX-99.1 | 4861
6 | GRAPHIC | tm2419051d1_ex99-1img001.jpg | GRAPHIC | 340440
7 | GRAPHIC | tm2419051d1_ex99-1img002.jpg | GRAPHIC | 395791
8 | GRAPHIC | tm2419051d1_ex99-1img003.jpg | GRAPHIC | 387795
| Complete submission text file | 0001104659-24-078451.txt |  | 1755119

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | carm-20240709.xsd | EX-101.SCH | 3018
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | carm-20240709_lab.xml | EX-101.LAB | 34240
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | carm-20240709_pre.xml | EX-101.PRE | 22361
19 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2419051d1_8k_htm.xml | XML | 3684

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 241106341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)